Viewing Study NCT06508320


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-25 @ 5:45 PM
Study NCT ID: NCT06508320
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2024-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)
Sponsor: ModernaTX, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
None SARS-CoV-2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Influenza View
None SARS-CoV-2 View
None mRNA-1083 View